Caspofungin as treatment for Candida glabrata hip infection.
Lejko-Zupanc
T
T
Mozina
E
E
Vrevc
F
F
D000368:Aged; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D041221:Candida glabrata / Q000187:drug effects / Q000302:isolation & purification*; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D055666:Lipopeptides; D015207:Osteoarthritis, Hip / Q000188:drug therapy* / Q000382:microbiology; D010456:Peptides, Cyclic / Q000494:pharmacology / Q000627:therapeutic use*; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D000077336:Caspofungin